Melbourne, Feb 13, 2008 (ABN Newswire) - Australia’s adult stem cell company, Mesoblast Limited (ASX: MSB)(USOTC:MBLTY), today announced highly successful results from its clinical trial at The Royal Melbourne Hospital in 10 patients suffering from non-healing, long bone fractures of the legs.
